Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality 100070

1 studies enrolling now · 6 studies all time

What they study most

Acute Ischemic Stroke, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Brain Edema, Early Alzheimer's Disease, Glioblastoma, Glioma, IDH1-mutant Glioma, Oligodendroglioma, Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Studies at this site

• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
• A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke — Completed
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed
• A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis — Status unconfirmed